製品名
抗phospho-ヒストンH2A.X (Ser139)抗体、クローンJBW301, clone JBW301, Upstate®, from mouse
biological source
mouse
antibody form
affinity purified immunoglobulin
clone
JBW301, monoclonal
species reactivity
vertebrates
packaging
antibody small pack of 25 μg
manufacturer/tradename
Upstate®
technique(s)
ChIP: suitable
immunocytochemistry: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
phosphorylation (pSer139)
Quality Level
Preparation Note
Legal Information
Physical form
Analysis Note
免疫細胞染色:2 μg/mLで使用、0.5 μMスタウロスポリンで4~6時間処理したHeLa細胞のリン酸化ヒストンH2A.Xを検出できます。
UV処理293細胞抽出物、UV処理HeLa細胞抽出物、または乳癌組織
Application
免疫組織染色:代表的なロットは、RNF168-WTおよびRNF 168-SA/SEKIマウス肺組織切片(パラフィン)のヒストンH2A.X(pSer139)を検出しました。(Xe, X., et al. (2015) Nat. Cell Biol. 20 (3); 320-331)。
クロマチン免疫沈降、技術情報タブのMeier, Andreas, et al. EMBO J., 26:2707-18 (2007) をご覧ください。
エピジェネティクス・核内機能分子
ヒストン
Biochem/physiol Actions
Disclaimer
General description
Immunogen
Other Notes
保管分類
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
資料
抗体の構造、クラス、イムノグロブリンの基準値範囲に関する技術情報など、抗体を利用した作業の基礎をご説明します。
抗体は特定の抗原と結合し、ユニークな抗原-抗体複合体を形成します。この結合の性質や、強固かつ特異的なこの結合を分子的標識として研究に使用する方法について説明します。
抗体がどのように産生されるのか、クローン数、抗体のフォーマットなど、モノクローナル抗体とポリクローナル抗体の違いを説明します。
Explore the basics of working with antibodies including technical information on structure, classes, and normal immunoglobulin ranges.
関連コンテンツ
Find protein research tools to prepare, isolate, and analyze proteins. Organized by how to extract, protect, purify, enrich, modify, and quantify proteins.
Western blotting is one of the most commonly used techniques in the lab, yet difficulties persist in obtaining consistent, quality results. We’ve been helping scientists publish their Western blots for decades, with continued innovation and steadfast technical support. Explore our expanded portfolio of products, including optimized reagents for chemiluminescent and Ḁuorescent Westerns, as well as the SNAP i.d.® system, which reduces blocking, washing and antibody incubation time from hours to minutes.
Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).
"Recognizing both the tremendous opportunities and the challenges facing cancer research, we are dedicated to developing and refining tools and technologies for the study of cancer. With our comprehensive portfolio, including the Upstate®, Chemicon®, and Calbiochem® brands of reagents and antibodies, researchers can count on dependable, high quality solutions for analyzing all the hallmarks of cancer."
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| 05-636 | 04053252588945 |
| 05-636-25UG | 04054839337697 |
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)